Retrospective cohort study of androgen deprivation therapy and the risk of diabetes in men with prostate cancer in Lithuania.

Mingaile Drevinskaite Ausvydas PatasiusMarius KinciusVincas UrbonasGiedre Smailytė

Published in: BMJ open (2021)

This study showed an increased risk of diabetes in patients with prostate cancer treated with ADT in comparison to ADT-free patient cohort. GnRH agonist users showed higher susceptibility, while the group on antiandrogen monotherapy showed no such increase.

Keyphrases

prostate cancer
type diabetes
radical prostatectomy
cardiovascular disease
glycemic control
case report
clinical trial
stem cells
open label
metabolic syndrome
insulin resistance
newly diagnosed